Announced
Synopsis
Delta Electronics, a Taiwan-based provider of power management and smart green solutions, agreed to acquire ACT Genomics, an oncology-focused genomics and diagnostics company, from Prenetics, a Hong Kong-based consumer health sciences company, for $72m. "Population ageing and the rising incidence of cancer worldwide are amplifying the demand for advanced healthcare. ACT Genomics has established a leading position in the NGS field in Asia, and we believe that its innovative technology can complement Delta’s resources and healthcare solutions portfolio," Ping Cheng, Delta Electronics Chairman and CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite
Vendor Team (7)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy